GB2050287B - Liposomes containing physiologically active substances - Google Patents

Liposomes containing physiologically active substances

Info

Publication number
GB2050287B
GB2050287B GB8014793A GB8014793A GB2050287B GB 2050287 B GB2050287 B GB 2050287B GB 8014793 A GB8014793 A GB 8014793A GB 8014793 A GB8014793 A GB 8014793A GB 2050287 B GB2050287 B GB 2050287B
Authority
GB
United Kingdom
Prior art keywords
active substances
physiologically active
liposomes containing
containing physiologically
liposomes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB8014793A
Other versions
GB2050287A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kureha Corp
Original Assignee
Kureha Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kureha Corp filed Critical Kureha Corp
Publication of GB2050287A publication Critical patent/GB2050287A/en
Application granted granted Critical
Publication of GB2050287B publication Critical patent/GB2050287B/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GB8014793A 1979-05-02 1980-05-02 Liposomes containing physiologically active substances Expired GB2050287B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP5428379A JPS55153713A (en) 1979-05-02 1979-05-02 Pharmaceutical preparation of ribosome containing active substance

Publications (2)

Publication Number Publication Date
GB2050287A GB2050287A (en) 1981-01-07
GB2050287B true GB2050287B (en) 1983-04-20

Family

ID=12966226

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8014793A Expired GB2050287B (en) 1979-05-02 1980-05-02 Liposomes containing physiologically active substances

Country Status (5)

Country Link
JP (1) JPS55153713A (en)
CA (1) CA1143656A (en)
DE (1) DE3016976A1 (en)
FR (1) FR2455458A1 (en)
GB (1) GB2050287B (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8182835B2 (en) 1997-09-18 2012-05-22 Pacira Pharmaceuticals, Inc. Sustained-release liposomal anesthetic compositions
US9585838B2 (en) 1997-11-14 2017-03-07 Pacira Pharmaceuticals, Inc. Production of multivesicular liposomes

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4692433A (en) * 1983-10-12 1987-09-08 The Regents Of The University Of California Method and composition for regulating serum calcium levels of mammals
WO1995013796A1 (en) * 1993-11-16 1995-05-26 Depotech Corporation Vesicles with controlled release of actives
JPS60152410A (en) * 1984-01-23 1985-08-10 Pola Chem Ind Inc External preparation for skin
CH668554A5 (en) * 1984-04-09 1989-01-13 Sandoz Ag LIPOSOMAS CONTAIN WHICH POLYPEPTIDES WITH INTERLEUKIN-2 ACTIVITY AND METHOD FOR THE PRODUCTION THEREOF.
JPS61100518A (en) * 1984-10-22 1986-05-19 Ono Pharmaceut Co Ltd Lyophilized ribosome pharmaceutical preparation comprising dimyristoylphosphatidylcholine as main component
GB8428222D0 (en) * 1984-11-08 1984-12-19 Bentall R H C Quantifying interaction of induced currents
US5023087A (en) * 1986-02-10 1991-06-11 Liposome Technology, Inc. Efficient method for preparation of prolonged release liposome-based drug delivery system
US4849227A (en) * 1986-03-21 1989-07-18 Eurasiam Laboratories, Inc. Pharmaceutical compositions
ATE115403T1 (en) * 1987-01-27 1994-12-15 Vestar Inc DOSAGE FORM CONSISTING OF PHOSPHOLIPIDS FOR WATER-INSOLUBLE ACTIVE SUBSTANCES.
US5723147A (en) * 1987-02-23 1998-03-03 Depotech Corporation Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride
US5811119A (en) * 1987-05-19 1998-09-22 Board Of Regents, The University Of Texas Formulation and use of carotenoids in treatment of cancer
US5811118A (en) * 1987-05-22 1998-09-22 The Liposome Company, Inc. Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations
AU617678B2 (en) * 1987-05-22 1991-12-05 Liposome Company, Inc., The Prostaglandin-lipid formulations
US5262168A (en) * 1987-05-22 1993-11-16 The Liposome Company, Inc. Prostaglandin-lipid formulations
US5925375A (en) * 1987-05-22 1999-07-20 The Liposome Company, Inc. Therapeutic use of multilamellar liposomal prostaglandin formulations
SE457933B (en) * 1987-07-06 1989-02-13 Larsson Kare PHARMACEUTICAL COMPOSITION INCLUDING A WATER DISPERSED MIXTURE OF LIPIDS, MONOGLYCERIDES AND PHOSPHATIDYLCOLINE AND ITS APPLICATION FOR THE PREPARATION OF A GASTRONIN TESTINALLY EFFECTIVE COMPOSITION
US5807572A (en) * 1988-02-18 1998-09-15 Depotech Corporation Multivesicular liposomes having a biologically active substance encapsulated therein in the presence of a hydrochloride
US5422120A (en) * 1988-05-30 1995-06-06 Depotech Corporation Heterovesicular liposomes
GB8822857D0 (en) * 1988-09-29 1988-11-02 Patralan Ltd Pharmaceutical formulations
FR2649610B1 (en) * 1989-07-13 1994-06-03 Dior Christian Parfums COSMETIC OR PHARMACEUTICAL AND PARTICULARLY DERMATOLOGICAL COMPOSITION CONTAINING AMPC OR ITS LIPOSOME DERIVATIVES
DE4005711C1 (en) * 1990-02-23 1991-06-13 A. Nattermann & Cie Gmbh, 5000 Koeln, De
DE4108902A1 (en) * 1990-08-06 1992-02-13 Nattermann A & Cie Aq. liposome systems
US5556637A (en) * 1990-08-06 1996-09-17 A. Nattermann & Cie. Gmbh Water containing liposome system
DE4107153A1 (en) * 1991-03-06 1992-09-10 Gregor Cevc Compsns. for application of active agents
DE4107152C2 (en) * 1991-03-06 1994-03-24 Gregor Cevc Preparations for non-invasive administration of antidiabetics
US6165500A (en) * 1990-08-24 2000-12-26 Idea Ag Preparation for the application of agents in mini-droplets
FR2685868B1 (en) * 1992-01-03 1995-06-23 Corbiere Jerome NOVEL PHARMACEUTICAL PREPARATIONS BASED ON PEPTIDES FOR THE GENERAL ROUTE.
WO1995001163A1 (en) * 1992-01-03 1995-01-12 Corbiere Jerome Novel pharmaceutical peptide preparations for general delivery
AU3442093A (en) * 1992-01-16 1993-08-03 Argus Pharmaceuticals, Inc. Formulation and use of carotenoids in treatment of cancer
IL101241A (en) * 1992-03-16 1997-11-20 Yissum Res Dev Co Pharmaceutical or cosmetic composition comprising stabilized oil-in-water type emulsion as carrier
US5989587A (en) * 1992-10-23 1999-11-23 National Research Council Of Canada Formation of stable liposomes from lipid extracts of archaeobacteria (archaeu)
JPH0657741U (en) * 1993-01-22 1994-08-12 株式会社村上開明堂 Mirror device with monitoring function
US5455044A (en) * 1993-05-14 1995-10-03 Depotech Corporation Method for treating neurological disorders
US5853755A (en) * 1993-07-28 1998-12-29 Pharmaderm Laboratories Ltd. Biphasic multilamellar lipid vesicles
IL107471A (en) * 1993-11-02 1997-09-30 Yissum Res Dev Co Pharmaceutical preparation comprising a self- emulsifying formulation and process for its production
US5840328A (en) * 1994-01-11 1998-11-24 The Liposome Company, Inc. Treatment using arachidonic acid metabolite and particulate formulations
AU3361595A (en) * 1994-08-08 1996-03-07 Argus Pharmaceuticals, Inc. Formulation and use of carotenoids in treatment of cancer
US5993850A (en) * 1994-09-13 1999-11-30 Skyepharma Inc. Preparation of multivesicular liposomes for controlled release of encapsulated biologically active substances
WO1996033697A1 (en) * 1995-04-24 1996-10-31 Yissum Research Development Company Of The Hebrew University Of Jerusalem Self-emulsifiable formulation producing an oil-in-water emulsion
US5931809A (en) 1995-07-14 1999-08-03 Depotech Corporation Epidural administration of therapeutic compounds with sustained rate of release
IL117773A (en) * 1996-04-02 2000-10-31 Pharmos Ltd Solid lipid compositions of coenzyme Q10 for enhanced oral bioavailability
US5997899A (en) 1996-10-01 1999-12-07 Skyepharma Inc. Method for producing liposomes with increased percent of compound encapsulated
CA2296056A1 (en) * 1997-07-10 1999-01-21 Keith Baker Methods for universally distributing therapeutic agents to the brain
US6306432B1 (en) 1997-09-08 2001-10-23 Chiron Corporation High and low load formulations of IGF-I in multivesicular liposomes
CN1320880C (en) 1998-12-23 2007-06-13 伊迪亚股份公司 Improved formulation for topical non-invasive application in vivo
ES2173679T3 (en) 1999-01-27 2002-10-16 Idea Ag IMMUNIZATION / TRANSNASAL TRANSPORTATION WITH HIGHLY ADAPTABLE VEHICLES.
EP1031346B1 (en) 1999-01-27 2002-05-02 Idea Ag Noninvasive vaccination through the skin
MXPA02000053A (en) 1999-07-05 2003-07-21 Idea Ag A method for the improvement of transport across adaptable semi-permeable barriers.
US20030068361A1 (en) * 2001-10-09 2003-04-10 Rimona Margalit Liposome-encapsulated insulin formulations
US7473432B2 (en) 2002-10-11 2009-01-06 Idea Ag NSAID formulations, based on highly adaptable aggregates, for improved transport through barriers and topical drug delivery
US20070248541A1 (en) * 2003-12-01 2007-10-25 Mitsubishi Pharma Corporation Liposome
CN103200932A (en) * 2010-06-23 2013-07-10 布莱特赛德创新有限公司 Lecithin carrier vesicles and methods of making the same
US20150182542A1 (en) * 2012-02-16 2015-07-02 Brightside Innovations, Inc. Dietary and nutritional compositions and methods of use
JP6661319B2 (en) * 2015-09-28 2020-03-11 小林製薬株式会社 Liposome
CN117205094A (en) * 2017-05-23 2023-12-12 大江生医股份有限公司 Use of emulsified liposome composition for preparing high temperature resistant liposome
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3060030A (en) * 1960-04-04 1962-10-23 Carl F Obenauf Lecithinated product
DE2249552A1 (en) * 1971-10-12 1973-05-30 Inchema S A PROCESS FOR THE INCAPSULATION OF IN PARTICULAR WATER-SOLUBLE COMPOUNDS
JPS5126213A (en) * 1974-08-21 1976-03-04 Tanabe Seiyaku Co JOHOSEIBIRYUSHISEIZAINO SEIHO
JPS5186117A (en) * 1975-01-27 1976-07-28 Tanabe Seiyaku Co Johoseibiryushiseizainoseiho
GB1575343A (en) * 1977-05-10 1980-09-17 Ici Ltd Method for preparing liposome compositions containing biologically active compounds
CA1119955A (en) * 1978-04-14 1982-03-16 Little (Arthur D.), Inc. Xenobiotic delivery vehicles, method of forming them and method of using them

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8182835B2 (en) 1997-09-18 2012-05-22 Pacira Pharmaceuticals, Inc. Sustained-release liposomal anesthetic compositions
US8834921B2 (en) 1997-09-18 2014-09-16 Pacira Pharmaceuticals, Inc. Sustained-release liposomal anesthetic compositions
US9192575B2 (en) 1997-09-18 2015-11-24 Pacira Pharmaceuticals, Inc. Sustained-release liposomal anesthetic compositions
US9205052B2 (en) 1997-09-18 2015-12-08 Pacira Pharmaceuticals, Inc. Sustained-release liposomal anesthetic compositions
US9585838B2 (en) 1997-11-14 2017-03-07 Pacira Pharmaceuticals, Inc. Production of multivesicular liposomes

Also Published As

Publication number Publication date
CA1143656A (en) 1983-03-29
FR2455458A1 (en) 1980-11-28
FR2455458B1 (en) 1983-04-15
GB2050287A (en) 1981-01-07
DE3016976A1 (en) 1980-11-13
JPS55153713A (en) 1980-11-29
JPH0240644B2 (en) 1990-09-12

Similar Documents

Publication Publication Date Title
GB2050287B (en) Liposomes containing physiologically active substances
GB2046092B (en) Pharmaceutical composition containing a lysophospholid and a phospholipid
GB2080682B (en) Antiherpetically active lipstick
IL61037A0 (en) Biologically active peptides
GB2103485B (en) Liposomes containing antimonyanti-leishmanaisis drugs
GB2049332B (en) Active filter
ZA804196B (en) Pharmaceutical formulations
GB2067176B (en) Demolition-facilitating substance
IL56621A0 (en) Novel electocatolytically active electrodes
JPS5697256A (en) Pharmacutically active peptides
JPS5697255A (en) Pharmacutically active peptides
JPS5697257A (en) Pharmaceutically active peptides
GB2049333B (en) Active filter
ZA793667B (en) N-arylsulfonylpyrroles,their preparation,and therapeutic agents containing these compounds
GB2048671B (en) Pharmaceutical composition containing dihydroegotoxine
JPS5697258A (en) Pharmaceutically active peptides
DE3174163D1 (en) Pharmaceutically active compounds
JPS55392A (en) Muramyllpeptide type novel compounds and drug containing them
JPS55108366A (en) Fireeextinguishing substance
DE3367719D1 (en) Biocidally active mixture
JPS53142538A (en) Active substance mixture
JPS568303A (en) Insecticide
AU535357B2 (en) Stable pharmaceutical solution
JPS5718612A (en) Biologically active mixture
DE3050070D2 (en) Cosmetic preparation

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee